MDIT Insider Trading Activity and SEC Form 4 Filings
MDIT insider trading summary
No open-market insider purchases or sales of Medite Cancer Diagnostics, Inc. (MDIT) have been reported on SEC Form 4 in the past 12 months.
Latest MDIT insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 15, 2018 | William Austin Lewis IV | Insider | Buy | $673K (8,973,333 @ $0.07) |
| Oct 15, 2018 | William Austin Lewis IV | Insider | Buy | $6K (80,000 @ $0.07) |
| Oct 11, 2018 | John H Abeles | Insider | Buy | $20K (266,667 @ $0.07) |
| Jul 27, 2018 | Rump Stephen L. Von | CEO / CFO | Buy | $10K (133,333 @ $0.07) |
| Jul 25, 2018 | William Austin Lewis IV | Insider | Buy | $83K (1,100,000 @ $0.07) |
| Jul 9, 2018 | William Austin Lewis IV | Insider | Buy | $520K (6,933,333 @ $0.07) |
| Jul 9, 2018 | William Austin Lewis IV | Insider | Buy | $30K (400,000 @ $0.07) |
| Jul 3, 2018 | John H Abeles | Insider | Buy | $30K (400,000 @ $0.07) |
| Jun 28, 2018 | William Austin Lewis IV | Insider | Buy | $100K (1,333,334 @ $0.07) |
| Apr 26, 2018 | William Austin Lewis IV | Insider | Buy | $600K (8,000,000 @ $0.07) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.